Michael Farkouh

All articles by Michael Farkouh

NSAIDS and CAD: Risks vs. Benefits

General (including evidence of efficacy) Various nonsteroidal antiinflammatory drugs (NSAIDS) are on the market worldwide. In general, the drugs are classified as traditional NSAIDS (i.e., naproxen, ibuprofen) versus cyclooxygenase-2 (COX-2) inhibitors (i.e., celecoxib). At doses tailored to equivalent pain relief, the different NSAIDS have very unique dosages. For example, for patients with osteoarthritis who often…

Next post in Cardiology